Thursday, August 16, 2012

Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 15 Issue 3

TABLE OF CONTENTS

Volume 15, Issue 3 (September 2012)

In this issue
Reviews
Original Articles

Also new
AOP

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Why publish in the Asian Journal of Andrology?
Efficient peer-review, hassle-free submission, recognition...

Papers benefit from wide readership through hosting on nature.com and inclusion in the leading abstracting and indexing services. Rapid publication is also assured through Advance Online Publication.
Review the complete list of AJA Author Benefits and submit your next article today!
 

Reviews

Top

Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior

G Gueron, A De Siervi and E Vazquez

Prostate Cancer Prostatic Dis 2012 15: 213-221; advance online publication, December 20, 2011; 10.1038/pcan.2011.64

Abstract | Full Text

Role of 5α-reductase inhibitors in benign prostatic diseases

F Azzouni and J Mohler

Prostate Cancer Prostatic Dis 2012 15: 222-230; advance online publication, February 14, 2012; 10.1038/pcan.2012.1

Abstract | Full Text

Role of denosumab in prostate cancer

S Helo, J P Manger and T L Krupski

Prostate Cancer Prostatic Dis 2012 15: 231-236; advance online publication, February 28, 2012; 10.1038/pcan.2012.2

Abstract | Full Text

Original Articles

Top

Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy

C Sevilla, S L Maliski, L Kwan, S E Connor and M S Litwin

Prostate Cancer Prostatic Dis 2012 15: 237-243; advance online publication, January 31, 2012; 10.1038/pcan.2011.71

Abstract | Full Text

MTHFR polymorphism and the risk of prostate cancer: a meta-analysis of case–control studies

X-L Li and J-H Xu

Prostate Cancer Prostatic Dis 2012 15: 244-249; advance online publication, February 28, 2012; 10.1038/pcan.2012.5

Abstract | Full Text

Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro

J Mani, S Vallo, K Barth, J Makarević, E Juengel, G Bartsch, C Wiesner, A Haferkamp and R A Blaheta

Prostate Cancer Prostatic Dis 2012 15: 250-255; advance online publication, March 27, 2012; 10.1038/pcan.2012.9

Abstract | Full Text

Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry

A Blana, C N Robertson, S C W Brown, C Chaussy, S Crouzet, A Gelet, G N Conti, R Ganzer, G Pasticier, S Thuroff and J F Ward

Prostate Cancer Prostatic Dis 2012 15: 256-259; advance online publication, April 10, 2012; 10.1038/pcan.2012.10

Abstract | Full Text

Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc-bearing animal model

H-W Chen, Y-F Chang, H-Y Chuang, W-T Tai and J-J Hwang

Prostate Cancer Prostatic Dis 2012 15: 260-264; advance online publication, May 8, 2012; 10.1038/pcan.2012.15

Abstract | Full Text

Body mass index and risk of BPH: a meta-analysis

S Wang, Q Mao, Y Lin, J Wu, X Wang, X Zheng and L Xie

Prostate Cancer Prostatic Dis 2012 15: 265-272; advance online publication, December 20, 2011; 10.1038/pcan.2011.65

Abstract | Full Text

The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based study

C Chong, L Fong, R Lai, W K O Lau, M Hartmann and S E Chia

Prostate Cancer Prostatic Dis 2012 15: 273-277; advance online publication, February 21, 2012; 10.1038/pcan.2011.69

Abstract | Full Text

Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy

R Dittrich, J Kurth, E A Decelle, E M DeFeo, M Taupitz, S Wu, C-l Wu, W S McDougal and L L Cheng

Prostate Cancer Prostatic Dis 2012 15: 278-282; advance online publication, January 31, 2012; 10.1038/pcan.2011.70

Abstract | Full Text

A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008

D M Marcus, M Goodman, A B Jani, A O Osunkoya and P J Rossi

Prostate Cancer Prostatic Dis 2012 15: 283-288; advance online publication, February 21, 2012; 10.1038/pcan.2012.4

Abstract | Full Text

Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy

M Kamrava, A H Kesarwala, R A Madan, E Lita, A Kaushal, K-Y Tsang, D J Poole, S M Steinberg, T Ferrara, W Dahut, J Schlom and J L Gulley

Prostate Cancer Prostatic Dis 2012 15: 289-295; advance online publication, March 6, 2012; 10.1038/pcan.2012.7

Abstract | Full Text

Testosterone recovery in the off-treatment time in prostate cancer patients undergoing intermittent androgen deprivation therapy

U W Tunn, G Canepa, A Kochanowsky and E Kienle

Prostate Cancer Prostatic Dis 2012 15: 296-302; advance online publication, June 26, 2012; 10.1038/pcan.2012.12

Abstract | Full Text

Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial

P-L Kellokumpu-Lehtinen, M Hjälm-Eriksson, C Thellenberg-Karlsson, L Åström, L Franzen, T Marttila, M Seke, M Taalikka and C Ginman for the SPCG-13

Prostate Cancer Prostatic Dis 2012 15: 303-307; advance online publication, May 1, 2012; 10.1038/pcan.2012.13

Abstract | Full Text

Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer

R B Egerdie, F Saad, M R Smith, T L J Tammela, J Heracek, P Sieber, C Ke, B Leder, R Dansey and C Goessl

Prostate Cancer Prostatic Dis 2012 15: 308-312; advance online publication, May 29, 2012; 10.1038/pcan.2012.18

Abstract | Full Text

Advertisement
Ensure your access to APS

Does your institution already subscribe to Clinical Pharmacology and Therapeutics, The Pharmacogenomics Journal and Nature Reviews Drug Discovery? If so - help your institution complete their collection with APS.

Recommend APS today.
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: